SCHEMBL72998

SCHEMBL72998

CCCCCc1c(O)ccc(O)c1CCCCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.57
PTGS2 P35354 4/20 0.50
CYP3A4 P08684 3/20 0.50
ESR1 P03372 2/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 2/20 0.50
TP53 P04637 2/20 0.50
HTT P42858 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
SHBG P04278 1/20 0.50
HSPD1 P10809 1/20 0.50
ADRB3 P13945 1/20 0.50
HTR2C P28335 1/20 0.50
HSPE1 P61604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27621118 0.98 TYR (0.55) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL8936594 0.98 TYR (0.60) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL6271499 0.98 TYR (0.60) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL3441358 0.98 TYR (0.60) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL10337301 0.98 TYR (0.60) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL5143093 0.98 TYR (0.60) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL30026986 0.92 HPGD (0.58) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL710654 0.92 HPGD (0.58) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL11328774 0.91 TYR (0.55) TYRPTGS2CYP3A4ESR1ADRA2A
SCHEMBL982873 0.89 TYR (0.53) TYRPTGS2CYP3A4ESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN CHORDA PHARMA INC (US) 2026-04-30 US claimed
WO-2025228825-A1 FILM COMPRISING POLYETHYLENE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2025-11-06 WO claimed
US-20250228759-A1 ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN SEASPIRE INC (US) 2025-07-17 US claimed
CN-119080973-A Sulfur-modified mesoporous carbon immobilized transition metal catalyst, preparation method thereof and application thereof in dicyclopentadiene polymerization reaction 长春三友智造科技发展有限公司 2024-12-06 CN claimed
WO-2023009502-A1 ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN SEASPIRE, INC. (US) 2023-02-02 WO claimed
US-20180015060-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC 2018-01-18 US claimed
EP-3250196-A1 HEALING TOPICAL COMPOSITION Florengale, LLC (US) 2017-12-06 EP claimed
WO-2016123223-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC (US) 2016-08-04 WO claimed
EP-2594248-A1 Active ingredient combination and use thereof Air Liquide Santé (International) (FR) 2013-05-22 EP claimed
US-20120171156-A1 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES HDS LTD. (GB) 2012-07-05 US claimed
US-20100310487-A1 ACTIVE INGREDIENT COMBINATION AND USE THEREOF AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2010-12-09 US claimed
EP-1301168-B1 STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS AIR LIQUIDE SANTE INT (FR) 2007-08-01 EP claimed
EP-1806123-A2 Storage-stable compositions of glycerol monoalkyl ethers Air Liquide Santé (International) (FR) 2007-07-11 EP claimed
US-20050238681-A1 Storage-stable compositions of glycerol monoalkyl ethers SCHULKE & MAYR GMBH (DE) 2005-10-27 US claimed
US-20030149097-A1 Storage-stable compositions of glycerol monoalkyl ethers ASHLAND SPECIALTIES DEUTSCHLAND GMBH (DE) 2003-08-07 US claimed
EP-1301168-A1 STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS Air Liquide Santé (International) (FR) 2003-04-16 EP claimed
WO-2001093825-A1 STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2001-12-13 WO claimed
US-4530770-A Oxidation resistance MOBIL OIL CORPORATION (US) 1985-07-23 US claimed
US-12636245-B2 Lipstick OLEON NV (BE) 2026-05-26 US disclosed
US-3935015-A Silver halide color photographic materials containing 3-anilino-5-pyrazolane couplers FUJI PHOTO FILM CO., LTD. (JA) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12636245-B2 Lipstick SYMPK, CUTA, LIPG TYR 202/4885PTGS2 1198/4885CYP3A4 3283/4885
US-20100310487-A1 ACTIVE INGREDIENT COMBINATION AND USE THEREOF POLR1C, CUTA, CAT TYR 5/4885PTGS2 2724/4885CYP3A4 1846/4885
US-20180015060-A1 HEALING TOPICAL COMPOSITION CUTA, CSDE1, SRI TYR 462/4885PTGS2 855/4885CYP3A4 2724/4885
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN TRPV1, SPTLC3, FFAR3 TYR 3075/4885PTGS2 607/4885CYP3A4 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.